Select Airway Specialized Proresolving Mediators Are Associated with Recovery from Nonviral Chronic Obstructive Pulmonary Disease Exacerbations

<b>Rationale:</b> Recovery from chronic obstructive pulmonary disease (COPD) exacerbations is heterogeneous and has a profound impact on disease trajectories. Resolution of airway inflammation is an active process that may be driven by specialized proresolving mediators (SPMs). <b>Objectives:</b> We sought to characterize the temporal change in SPMs in the sputum of patients with COPD during exacerbations, their association with exacerbation triggers, and exacerbation recovery. <b>Methods:</b> Participants were recruited from the London COPD Exacerbation Cohort between January 11, 2016, and April 30, 2018. Participants were reviewed at baseline, exacerbation onset, 1 week, 2 weeks, and 6 weeks during their exacerbation recovery. Sputum collection, nasopharyngeal swabs, phlebotomy, quality-of-life questionnaires, and spirometry were performed at each visit. SPMs were measured in sputum by liquid chromatography-tandem mass spectrometry. Respiratory viruses were measured by quantitative PCR and bacteria by microbiological culture. <b>Measurements and Main Results:</b> There were 68 exacerbations during the study period. Median time to symptomatic recovery was 21 days for viral exacerbations, compared with 13 days in nonviral exacerbations (<i>P</i> < 0.001). There was a significant increase in resolvin D1 (RvD1) at exacerbation onset in bacterial exacerbations but not in viral exacerbations. Lower levels of RvD1 were associated with prolonged respiratory symptoms during the 1-week and 2-week recovery time points. Exogenous RvD1 significantly reduced IL-6 and CXCL8 response to rhinovirus infection in COPD bronchial epithelial cells. <b>Conclusions:</b> There is a dynamic temporal change in airway SPMs during COPD exacerbations. Reduced levels of RvD1 were associated with prolonged respiratory symptoms. SPMs may be a potential therapeutic approach to promote exacerbation recovery.

Authors

Institutions

Publication Details

Journal
American Journal of Respiratory and Critical Care Medicine
Published
2025-03-05
DOI
https://doi.org/10.1164/rccm.202407-1325oc
Citations
6
Primary Topic
Neonatal Respiratory Health Research
Type
article
Field-Weighted Citation Impact
9.11
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Select Airway Specialized Proresolving Mediators Are Associated with Recovery from Nonviral Chronic Obstructive Pulmonary Disease Exacerbations

Jadwiga A. Wedzicha, Christopher Michael Orton, Dexter Wiseman, Alexander Mackay et al.
6 citations
American Journal of Respiratory and Critical Care Medicine
Neonatal Respiratory Health Research
9.11
article

Select Airway Specialized Proresolving Mediators Are Associated with Recovery from Nonviral Chronic Obstructive Pulmonary Disease Exacerbations

Jadwiga A. Wedzicha, Christopher Michael Orton, Dexter Wiseman, Alexander Mackay, Tata Kebadze, Faisal Kamal, Pankaj Kumar Bhavsar, Andrew I. Ritchie, Bruce David Levy, Sebastian Lennox Johnston, Aran Singanayagam, James P. Allinson, Adam J. Byrne, Lydia Finney, Federico Baraldi, Samuel V. Kemp, Melody G. Duvall, Mairi Macleod, Peter Fenwick, Jordina Mah
article en
6 citations

Abstract

<b>Rationale:</b> Recovery from chronic obstructive pulmonary disease (COPD) exacerbations is heterogeneous and has a profound impact on disease trajectories. Resolution of airway inflammation is an active process that may be driven by specialized proresolving mediators (SPMs). <b>Objectives:</b> We sought to characterize the temporal change in SPMs in the sputum of patients with COPD during exacerbations, their association with exacerbation triggers, and exacerbation recovery. <b>Methods:</b> Participants were recruited from the London COPD Exacerbation Cohort between January 11, 2016, and April 30, 2018. Participants were reviewed at baseline, exacerbation onset, 1 week, 2 weeks, and 6 weeks during their exacerbation recovery. Sputum collection, nasopharyngeal swabs, phlebotomy, quality-of-life questionnaires, and spirometry were performed at each visit. SPMs were measured in sputum by liquid chromatography-tandem mass spectrometry. Respiratory viruses were measured by quantitative PCR and bacteria by microbiological culture. <b>Measurements and Main Results:</b> There were 68 exacerbations during the study period. Median time to symptomatic recovery was 21 days for viral exacerbations, compared with 13 days in nonviral exacerbations (<i>P</i> < 0.001). There was a significant increase in resolvin D1 (RvD1) at exacerbation onset in bacterial exacerbations but not in viral exacerbations. Lower levels of RvD1 were associated with prolonged respiratory symptoms during the 1-week and 2-week recovery time points. Exogenous RvD1 significantly reduced IL-6 and CXCL8 response to rhinovirus infection in COPD bronchial epithelial cells. <b>Conclusions:</b> There is a dynamic temporal change in airway SPMs during COPD exacerbations. Reduced levels of RvD1 were associated with prolonged respiratory symptoms. SPMs may be a potential therapeutic approach to promote exacerbation recovery.

American Journal of Respiratory and Critical Care MedicineVol. 211(5)
University College Dublin (IE), Brigham and Women's Hospital (US), Boston Children's Hospital (US), British Airways (United Kingdom) (GB), Nottingham University Hospitals NHS Trust (GB), University of Ferrara (IT), Royal Brompton Hospital (GB), Center for Pain and the Brain (US), Imperial College London (GB)
Openalex Percentile: Top 2%
Neonatal Respiratory Health Research
9.11
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.